<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/24023" />
  <subtitle />
  <id>http://repository.usmf.md:80/handle/20.500.12710/24023</id>
  <updated>2026-04-19T21:52:17Z</updated>
  <dc:date>2026-04-19T21:52:17Z</dc:date>
  <entry>
    <title>The role of an optometrist in medical system of the Republic of Moldova</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/24120" />
    <author>
      <name>Gavriliuc, Tatiana</name>
    </author>
    <author>
      <name>Ghidirimschi, Tatiana</name>
    </author>
    <author>
      <name>Bakketeig, Hans Bjorn</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/24120</id>
    <updated>2023-04-14T08:09:50Z</updated>
    <published>2021-01-01T00:00:00Z</published>
    <summary type="text">Title: The role of an optometrist in medical system of the Republic of Moldova
Authors: Gavriliuc, Tatiana; Ghidirimschi, Tatiana; Bakketeig, Hans Bjorn
Abstract: Background: In 2017 optometry specialty was established at Nicolae Testemitanu State&#xD;
University of Medicine and Pharmacy of the Republic of Moldova, decision approved by the&#xD;
Government (HG Nr. 482/2017). The first class of optometrists graduated in June 2021, and is&#xD;
going to be engaged in national primary health care. High prevalence of visual impairments and&#xD;
increasing incidence of eye diseases represent the premises of optometry establishment as a&#xD;
specialty in the Republic of Moldova. According to Vision Atlas, in 2020 in the Republic of&#xD;
Moldova, there were an estimated number of 830 000 people with vision loss, of these, 19 000&#xD;
people were blind. In comparison with neighbouring countries (Romania, Ukraine), Republic of&#xD;
Moldova is distinguished by its higher prevalence of vision loss of 22%, followed by Ukraine with&#xD;
a prevalence of 19% and Romania with 18%. Thus, Eastern Europe faces a high prevalence of&#xD;
visual impairments compared to Western and Northern European countries. The prevalence of&#xD;
visual impairments is 22.4%, and blindness is 0.50%. In this context, the optometrist will have a&#xD;
vital role in the prophylaxis of visual impairments and the prevention of preventable blindness.&#xD;
Objective of the Study: To describe the role of an optometrist in the assessment of visual&#xD;
impairments; to assess the public’s knowledge and attitude regarding the new specialty.&#xD;
Materials and Methods: A descriptive, sociological study was performed, based on a populationbased random questionnaire. Observational, historical, statistical and comparative methods were&#xD;
applied. Public’s knowledge of the differences between ophthalmologists and optometrists was&#xD;
estimated.&#xD;
Results: The questionnaire was completed by 110 people, females represented 60.9% (n = 67) of&#xD;
the total number of respondents, and males 39.1% (n = 43). A similar distribution by genre can be&#xD;
noticed in the study Gaurav Dubey, 2019, with an inverse value. Participants from urban areas&#xD;
constitute 66% (n = 73) and from rural areas - 34% (n = 37). Their clinical profile showed previous&#xD;
spectacle or contact lens wear 59.1% (n = 65), other 40.9% (n = 45) do not have such experience.&#xD;
Therefore, more than a half of participants interacted with national ophthalmological medical&#xD;
system.&#xD;
The majority 74.5% (n = 82) of the respondents reported a high level of awareness of the optometry&#xD;
term, only 25.5% (n = 28) had never interacted with the given term. Respondents chose the&#xD;
exclusive responsibility of optometrists, in order to assess their knowledge of the differences&#xD;
between ophthalmologists and optometrists. The respondents when asked about the optometrist&#xD;
functions (multiple choice questions used), so (46.2%), thinks the optometrist prescribes spectacles&#xD;
and contact lenses; (26.8%) – sells glasses and chooses frames; (18.28%) – diagnoses eye diseases.&#xD;
Nevertheless, the wrong options as medical treatment of eye diseases (7.4%) and surgical treatment&#xD;
(1.1%) were selected as well. The connection between selecting wrong options and&#xD;
educational/economic status has not been established.&#xD;
Educational and professional status of the respondents determined a high level of awareness&#xD;
according to the results of the research. It is recommended to include participants with a more&#xD;
variable socio-demographic status, in order to ensure a higher representativity of the population in the next conducted surveys. These findings of the questionnaire seem to indicate only the general&#xD;
tendency among the society.&#xD;
Conclusions: Optometry as a health care field remains to be explored, as it is a new specialty in&#xD;
Republic of Moldova. The evolution of optometry is accelerated all over the world, however it is&#xD;
geographically dispersed. The study showed a relatively high level of public knowledge regarding&#xD;
optometry, among people with secondary/higher, medical degree. Also, there is an essential&#xD;
demand of more complex researches among people with variable representative sample.</summary>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Atropine use in myopia control</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/24115" />
    <author>
      <name>Șcerbatiuc, Cristina</name>
    </author>
    <author>
      <name>Bendelic, Eugeniu</name>
    </author>
    <author>
      <name>Paduca, Ala</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/24115</id>
    <updated>2023-04-12T07:41:27Z</updated>
    <published>2021-01-01T00:00:00Z</published>
    <summary type="text">Title: Atropine use in myopia control
Authors: Șcerbatiuc, Cristina; Bendelic, Eugeniu; Paduca, Ala
Abstract: Atropine is currently the most effective therapy for myopia control. Recent clinical trials&#xD;
demonstrated low-dose atropine eye drops such as 0.01% resulted in retardation of myopia&#xD;
progression, with less side effects compared to higher concentration preparation. For children aged&#xD;
6-10 years with myopia of at least 1D and myopia progression of at least 0.50D per year, the WHO&#xD;
recommends atropine as a potential first line treatment for myopia. Proposed strategies include a&#xD;
combination of low-dose atropine with increase outdoor time.&#xD;
We made pilot study and 1-year results suggest that atropine 0.01% eyedrops can slow myopia&#xD;
progression and axial elongation of the eye.</summary>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Myopia course. Guidance on management of myopia</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/24114" />
    <author>
      <name>Németh, János</name>
    </author>
    <author>
      <name>Tapasztó, Beáta</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/24114</id>
    <updated>2023-04-12T07:34:15Z</updated>
    <published>2021-01-01T00:00:00Z</published>
    <summary type="text">Title: Myopia course. Guidance on management of myopia
Authors: Németh, János; Tapasztó, Beáta
Abstract: The prevalence of myopia is increasing extensively worldwide. The number of people with myopia&#xD;
in 2020 is predicted to be 2.6 billion globally, which is expected to rise up to 4.9 billion by 2050,&#xD;
unless preventive actions and interventions are taken. The number of individuals with high myopia&#xD;
is also increasing substantially and pathological myopia is predicted to become the most common&#xD;
cause of irreversible vision impairment and blindness worldwide and also in Europe.&#xD;
These prevalence estimates indicate the importance of reducing the burden of myopia by means of&#xD;
myopia control interventions to prevent myopia onset and to slow down myopia progression. Due&#xD;
to the urgency of the situation, the European Society of Ophthalmology (SOE) in cooperation with&#xD;
International Myopia Institute (IMI) published an article, an update of the current information and&#xD;
guidance on management of myopia in the European Journal of Ophthalmology 2021; 31(3): 853-&#xD;
883. (See also online, open access at&#xD;
https://journals.sagepub.com/doi/full/10.1177/1120672121998960 ).</summary>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>The effect of COVID-19 home confinement on myopia progression in children</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/24113" />
    <author>
      <name>Bulut, Asker</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/24113</id>
    <updated>2023-04-12T07:30:28Z</updated>
    <published>2021-01-01T00:00:00Z</published>
    <summary type="text">Title: The effect of COVID-19 home confinement on myopia progression in children
Authors: Bulut, Asker
Abstract: Purpose: The aim of this study is to investigate the effect of COVID-19 Home Confinement on&#xD;
the increase of myopia in the pediatric age group.&#xD;
Methods: For this purpose, the files of myopic patients under 18 years of age who were examined&#xD;
in the outpatient clinic in the last year were analyzed retrospectively. Subjective refraction values&#xD;
determined from the patients' files in 2018, 2019, 2020 and 2021 examinations between March&#xD;
and May were examined. Myopic progression over the years was analyzed by calculating the&#xD;
manifest refraction spherical equivalent (RMSE) value. Exclusion criteria were ocular disease,&#xD;
refractive error of 1 diopter or more, degenerative myopia, ocular surgery history, ocular trauma&#xD;
history, and collagen tissue disease.&#xD;
Results: The mean age of 310 patients who met the criteria included in the study was 15.08 ± 2.02&#xD;
years, and 218 (70.3%) were female and 92 (29.7%) were male. The mean MRSE values of the&#xD;
patients were found to be -1.83 ± 1.19 in 2018, -2.14 ± 1.26 in 2019, -2.46 ± 1.36 in 2020 and -&#xD;
3.12 ± 1.36 in 2021. Accordingly, between 2018-2019, -0.31 ± 0.21 D (P &lt;0.001), between 2019-&#xD;
2020 -0.31 ± 0.25 D (P &lt;0.001), between 2020-2021 -0.65 ± 0.29 D (P &lt;0.001) it was observed&#xD;
that there was an increase in myopia.&#xD;
Conclusion: Although myopia in childhood seems progressive at all times, it has progressed more&#xD;
significantly during the COVID-19 Home Confinement , possibly with the effect of spending more&#xD;
time in closed environment and increasing indoor activity.</summary>
    <dc:date>2021-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

